Blood Pressure and Subclinical Organ Damage
Vasorisk
Central and Peripheral Blood Pressure and Its Relation With Vascular Target Organ Damage in Carotid, Retinal and Arterial Stiffness. Developed and Validation of a Tool
1 other identifier
observational
500
1 country
1
Brief Summary
Background: The purpose of this study is to analyze the relationship between central and peripheral blood pressure (clinic and ambulatory) with vascular structure and function, assessed by carotid intima-media thickness (IMT), artery venous retinal index, pulse wave velocity (PWV) and ankle-brachial index in patients with diabetes type 2 and without diabetes type 2. Develop and validate a software to measure the retinal vessels and to estimate arterio-venous index automatically. Methods/design: The investigators will Perform a coss-sectional study with control group, with follow-up of 4 years in primary care. The study population will be diabetic type 2 patients with a control group without diabetes mellitus. The investigators will include by consecutive sampling 300 patients between 34 and 75 and without previous cardiovascular disease, half of each group. Main measurements: age, sex, height, weight and waist circumference. Lipids, creatinine, microalbuminuria, blood glucose, HbA1C, insulin, fibrinogen, hs-CRP and markers of endothelial dysfunction. Clinic and ambulatory blood pressure (MAPA). Ultrasonography to assess carotid IMT, retinography to assess arterio-venous ratio. ECG to evaluate left ventricular hypertrophy, ankle-brachial index and morphology analysis (PWA) and pulse wave velocity (PWV) in Sphigmocor System. Discussion: The investigators provide information regarding various parameters derived from MAPA and pulse wave analysis of with target organ damage, especially with the vascular structure and function assessed by IMT and PWV and endothelial dysfunction in patients with diabetes type 2 and without this disease. The investigators also hope to demonstrate the usefulness of the tool developed for automatic evaluation of retinal vascularization in the early detection of abnormalities of vascular structure and function and the prognosis of cardiovascular disease in the medium term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 27, 2011
CompletedFirst Posted
Study publicly available on registry
March 29, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFebruary 21, 2020
August 1, 2016
6 months
March 27, 2011
February 20, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
subclinical organ damage
december, 1 2013
Eligibility Criteria
The study population will be diabetic type 2 patients with a control group without diabetes mellitus. We will include by consecutive sampling 300 patients between 34 and 75 and without previous cardiovascular disease, half of each group.
You may qualify if:
- Patients aged 34 years or more but less than 75 years, with and without type 2 diabetes.
You may not qualify if:
- Patients who fail to meet the requirements of the protocol (mental disorders and / or cognitive uncooperative, education and understanding limitations),
- Patients with ischemic heart disease, cerebrovascular disease or other atherosclerotic disease
- Patients who are participating or will participate in a clinical trial during the study
- Patients with serious comorbidity that might endanger his life in the next 12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Luis Garcia Ortiz
Salamanca, 37003, Spain
Related Publications (9)
Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, Agudo-Conde C, Fernandez-Alonso C, Martinez Vizcaino V, Cantera CM, Guenaga-Saenz N, Gonzalez-Viejo N, Garcia-Ortiz L; EVIDENT Study, Spain. Electrocardiographic left ventricular hypertrophy criteria and ambulatory blood pressure monitoring parameters in adults. Am J Hypertens. 2014 Mar;27(3):355-62. doi: 10.1093/ajh/hpt198. Epub 2013 Nov 4.
PMID: 24190901DERIVEDGomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Gomez-Sanchez L, Gomez-Sanchez M, Garcia-Ortiz L; Vasorisk group. Relationship between uric acid and vascular structure and function in hypertensive patients and sex-related differences. Am J Hypertens. 2013 May;26(5):599-607. doi: 10.1093/ajh/hps097. Epub 2013 Feb 26.
PMID: 23443729DERIVEDGarcia-Garcia A, Garcia-Ortiz L, Recio-Rodriguez JI, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Gomez-Marcos MA. Relationship of 24-h blood pressure variability with vascular structure and function in hypertensive patients. Blood Press Monit. 2013 Apr;18(2):101-6. doi: 10.1097/MBP.0b013e32835ebc58.
PMID: 23388405DERIVEDGarcia-Ortiz L, Recio-Rodriguez JI, Rodriguez-Sanchez E, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Martin C, Castano-Sanchez C, Runkle I, Gomez-Marcos MA. Sodium and potassium intake present a J-shaped relationship with arterial stiffness and carotid intima-media thickness. Atherosclerosis. 2012 Dec;225(2):497-503. doi: 10.1016/j.atherosclerosis.2012.09.038. Epub 2012 Oct 5.
PMID: 23084712DERIVEDGarcia-Garcia A, Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, Rodriguez-Sanchez E, Agudo-Conde C, Garcia-Ortiz L; Vaso-risk group. Office and 24-hour heart rate and target organ damage in hypertensive patients. BMC Cardiovasc Disord. 2012 Mar 22;12:19. doi: 10.1186/1471-2261-12-19.
PMID: 22439900DERIVEDRecio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Garcia-Ortiz L; Vaso-Risk group. Cocoa intake and arterial stiffness in subjects with cardiovascular risk factors. Nutr J. 2012 Feb 10;11:8. doi: 10.1186/1475-2891-11-8.
PMID: 22325068DERIVEDGarcia-Ortiz L, Recio-Rodriguez JI, Parra-Sanchez J, Gonzalez Elena LJ, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Gomez-Marcos MA; Vaso-risk group. A new tool to assess retinal vessel caliber. Reliability and validity of measures and their relationship with cardiovascular risk. J Hypertens. 2012 Apr;30(4):770-7. doi: 10.1097/HJH.0b013e3283506628.
PMID: 22306849DERIVEDRecio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Garcia-Ortiz L; Vasorisk group. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive. BMC Cardiovasc Disord. 2012 Feb 1;12:3. doi: 10.1186/1471-2261-12-3.
PMID: 22292502DERIVEDGarcia-Ortiz L, Ramos-Delgado E, Recio-Rodriguez JI, Agudo-Conde C, Martinez-Salgado C, Patino-Alonso MC, Rodriguez-Sanchez E, Gomez-Marcos MA; Vaso risk group. Peripheral and central arterial pressure and its relationship to vascular target organ damage in carotid artery, retina and arterial stiffness. Development and validation of a tool. The Vaso risk study. BMC Public Health. 2011 Apr 27;11:266. doi: 10.1186/1471-2458-11-266.
PMID: 21524299DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Manuel A Gomez
Infoslaud Fundation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2011
First Posted
March 29, 2011
Study Start
June 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2014
Last Updated
February 21, 2020
Record last verified: 2016-08